Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2023 –2030 | |
|
|
USD 100.00 Million |
| USD 126.68 Million | |
| % | |
|
Global Intra-Uterine Therapies Market, By Surgery Type (Minimally Invasive, Non-Invasive, Others), Application (Erythroblastosis Fetalis, Congenital Diaphragmatic Hernia (CDH), Urinary Tract Obstruction, Fetal Tumors Causing Hydrops Fetalis, Twin-Twin Transfusion Syndrome (TTTS), Meningomyelocele (MMC), Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
During the past few years, a constant rise in infertility rate is witnessed as people suffer from diseases such as erectile dysfunction and Polycystic Ovary Syndrome (PCOS). The technological advancements in the Intrauterine Insemination (IUI) technique are surging the chances to conceive. Currently, people are becoming more aware of the intrauterine insemination procedure because of the increasing awareness efforts presented by the public health foundations.
Data Bridge Market Research analyses a growth rate in the intra-uterine therapies market in the forecast period 2023-2030. The expected CAGR of intra-uterine therapies market is tend to be around 3% in the mentioned forecast period. The market is valued at USD 100 million in 2022, and it will grow upto USD 126.68 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Surgery Type (Minimally Invasive, Non-Invasive, Others), Application (Erythroblastosis Fetalis, Congenital Diaphragmatic Hernia (CDH), Urinary Tract Obstruction, Fetal Tumors Causing Hydrops Fetalis, Twin-Twin Transfusion Syndrome (TTTS), Meningomyelocele (MMC), Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Aetna Inc.(U.S.), Cardinal Health. (U.S.), WomanCare Centers (U.S.), Mayo Foundation for Medical Education and Research (MFMER) (U.S.), The Johns Hopkins Health System Corporation. (U.S.), Duke University Health System (U.S.), EvergreenHealth (U.S.), Bayer AG (Germany)
|
|
Market Opportunities
|
|
Market Definition
The Intrauterine Insemination (IUI) is minimally invasive and cost-effective first-line therapy for patients than the other fertility treatment options. The aim of this treatment is to improve the chances of fertilization by growing the number of healthy sperm that reach the fallopian tubes when the woman is most fertile. This treatment is performed during an ovulation cycle. In most of the patients, most commonly the fertility medication, such as Clomid is used to stimulate ovulation
Drivers
In the last few years, a constant rise in infertility rate is witnessed as people are suffering from diseases such as erectile dysfunction and Polycystic Ovary Syndrome (PCOS).The alteration and disruption in lifestyle and people wanting children later in life may cause some complications. As per the National Women’s Health Resource Center, infertility affects almost 20 million women. In 2017, United Nations World Population Prospects report anticipated that the total fertility rate would reduce from 2.43 to 2.39 (children per woman) between the years 2020 and 2030. This growing occurrence of infertility among the world’s population is boosting the Intrauterine Insemination (IUI) Devices market forward. Thus, this factor boosts the market growth.
Opportunities
People are becoming more aware of the intrauterine procedure due to the awareness efforts presented by the public health foundations, the demand of these devices are boosting the market growth. Additionally, governments of respective countries are taking numerous initiatives, which is in turn boosting the market growth worldwide. For instance, the Union Cabinet of India approved Assistive Reproductive Technology Regulation Bill 2020 to regulate clinics providing safe and ethical ART services to infertile couples. Numerous government modifications in laws favouring same sex couples and single parents is going to incraese the market growth. This as a result, increases the demand for the market.
The technological advancement in the Intrauterine Insemination (IUI) technique is growing the chances to conceive. Technological advances in automation and AI enable higher success rates by monitoring hormonal levels combined with other health parameters, increasing market growth in the upcoming years. Furthermore, numerous emerging FemTech companies are now providing market particular products and have therefore presented opportunities for market development of intrauterine insemination devices. For instance, GE Healthcare (US) and Vitrolife AB partnered to enhance the patient outcomes in assisted reproductive technology in June 2018. Thus, this factor boosts the market growth.
Restraints/Challenges
The high cost related with the treatment procedures hamper the market growth. These intra uterine therapies specifically intrauterine insemination, cost high and people in the highly developing and underdeveloped countries, cause the under-treatment of several patients. This impedes the market growth.
This intra-uterine therapies market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the intra-uterine therapies market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
The intra-uterine therapies market is segmented on the basis of surgery type, application, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Surgery Type
Application
End User
Distribution Channel
The intra-uterine therapies market is analyzed and market size insights and trends are provided by surgery type, application, end-user and distribution channel as referenced above.
The major countries covered in the intra-uterine therapies market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America has been witnessing a positive growth for intra-uterine therapies market throughout the forecasted period because of the increasing awareness among people regarding the benefits related with therapies.
Asia-Pacific dominates the market because of the increasing incidences of cancer and other diseases. The increased technological advancements in assisted reproductive technologies and other procedures led to the market's growth.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
The intra-uterine therapies market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to intra-uterine therapies market.
Key players operating in the intra-uterine therapies market include:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.